Model
Edge
Actinium Pharmaceuticals Inc.
ATNM
Filing type
S-8
Filing date
Aug 18, 2022
Updated
Aug 19, 2022 ยท 11:01 AM
Copy reference
Filing
S-8
Registration Statement for Securities to be Offered to Employees
Exhibits
EX-5.1
OPINION OF HAYNES AND BOONE, LLP.
EX-23.1
CONSENT OF MARCUM LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.
EX-99.4
THIRD AMENDMENT TO THE ACTINIUM PHARMACEUTICALS, INC. 2019 STOCK PLAN
EX-FILING FEES
FILING FEE TABLE